Patents by Inventor Robert MEHLER

Robert MEHLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cardiovascular Risk Event Prediction and Uses Thereof
    Publication number: 20200166523
    Abstract: The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the evaluation of risk of a caradiovascular (CV) Event within 5 years. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to evaluate risk of a CV event within 5 years. In another aspect, methods are provided for evaluating risk of a CV event within 5 years in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 1. In a further aspect, methods are provided for evaluating the risk of a CV, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 2.
    Type: Application
    Filed: January 23, 2020
    Publication date: May 28, 2020
    Applicant: SomaLogic, Inc.
    Inventors: Rosalynn Dianne GILL, Stephen Alaric WILLIAMS, Alec A.E. STEWART, Robert MEHLER, Trudi FOREMAN, Britta SINGER
  • COMPOSITIONS AND METHODS FOR IDENTIFYING, MODULATING AND MONITORING DRUG TARGETS IN MUSCULAR DISEASE
    Publication number: 20180284136
    Abstract: The present disclosure relates to customized therapy for disease. The present disclosure also relates to aptamer-based compositions and methods for identifying, modulating and monitoring drug targets in muscular disease (e.g., Duchenne muscular dystrophy).
    Type: Application
    Filed: January 24, 2018
    Publication date: October 4, 2018
    Applicant: SomaLogic, Inc.
    Inventors: Larry Gold, Robert Kirk DeLisle, David Sterling, Edward Brody, Britta Singer, Robert Mehler
  • COMPOSITIONS AND METHODS FOR IDENTIFYING, MODULATING AND MONITORING DRUG TARGETS IN MUSCULAR DISEASE
    Publication number: 20160324927
    Abstract: The present disclosure relates to customized therapy for disease. The present disclosure also relates to aptamer-based compositions and methods for identifying, modulating and monitoring drug targets in muscular disease (e.g., Duchenne muscular dystrophy).
    Type: Application
    Filed: May 2, 2016
    Publication date: November 10, 2016
    Inventors: Larry Gold, Kirk DeLisle, David Sterling, Edward Brody, Britta Singer, Robert Mehler
  • Cardiovascular Risk Event Prediction and Uses Thereof
    Publication number: 20150168423
    Abstract: The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the evaluation of risk of a caradiovascular (CV) Event within 5 years. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to evaluate risk of a CV event within 5 years. In another aspect, methods are provided for evaluating risk of a CV event within 5 years in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 1. In a further aspect, methods are provided for evaluating the risk of a CV, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 2.
    Type: Application
    Filed: December 31, 2013
    Publication date: June 18, 2015
    Applicant: SOMALOGIC, INC.
    Inventors: Rosalynn Dianne GILL, Stephen Alaric WILLIAMS, Alex A.E. STEWART, Robert MEHLER, Trudi FOREMAN, Britta SINGER